Agilent (NYSE:A) Reports Q4 CY2025 In Line With ExpectationsLife sciences tools company Agilent Technologies (
NYSE:A) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 7% year on year to $1.8 billion. The company expects next quarter’s revenue to be around $1.81 billion, coming in 2.2% above analysts’ estimates. Its non-GAAP profit of $1.36 per share was in line with analysts’ consensus estimates.
Agilent Reports First-Quarter Fiscal Year 2026 Financial Results
Agilent Technologies, Inc. (
NYSE: A) today reported revenue of $1.80 billion for the first quarter ended Jan. 31, 2026, representing growth of 7.0% reported and up 4.4% core(1) compared with the first quarter of 2025.
What To Expect From Agilent’s (A) Q4 EarningsLife sciences tools company Agilent Technologies (
NYSE:A)
will be reporting earnings this Wednesday afternoon. Here’s what you need to know.
Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference
Agilent Technologies Inc. (
NYSE: A) today announced that Chief Financial Officer Adam Elinoff and Head of Investor Relations Tejas Savant will participate in a fireside chat at TD Cowen’s 46th Annual Health Care Conference. The event is scheduled for 11:10 to 11:40 a.m. EST on Tuesday, March 3, 2026, in Boston, Massachusetts. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website.
Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo PivotAs of February 17, 2026, Danaher Corporation (
NYSE: DHR) finds itself at a pivotal juncture in its multi-decade evolution. Once the darling of the "compounding" investment community, the Washington, D.C.-based life sciences giant has recently seen its share price retreat from 2025 highs, currently trading down approximately 11% year-to-date. This volatility follows a complex narrative: [...]
1 S&P 500 Stock to Keep an Eye On and 2 We AvoidThe S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.
Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
3 Profitable Stocks We Steer Clear OfEven if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)
Agilent Technologies Inc. (
NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code SK006, as the only FDA-approved companion diagnostic indicated to aid in identifying patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma (EOC), whose tumors express PD-L1 and who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy.
Agilent Announces Cash Dividend of 25.5 Cents per Share
Agilent Technologies Inc. (
NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on April 22, 2026, to all shareholders of record as of the close of business on March 31, 2026.
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award
Agilent Technologies Inc. (
NYSE: A) today announced that Boehringer Ingelheim has been selected as the winner of Agilent’s inaugural Instrument Trade‑In Impact Award, recognizing exceptional sustainability leadership demonstrated through their participation in Agilent’s trade‑in and buyback program.
The Measurement Giant Reimagined: A Deep Dive into Waters Corporation (WAT) in 2026As of February 10, 2026, Waters Corporation (
NYSE: WAT) stands at the most significant crossroads in its nearly 70-year history. Long regarded as the gold standard in liquid chromatography and mass spectrometry, the Milford, Massachusetts-based company has recently transitioned from a specialized toolmaker into a multi-disciplinary life sciences juggernaut. With the closing of its massive [...]
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026
Agilent Technologies Inc. (
NYSE: A) announced today that it will present a range of next‑generation automated workflow innovations at the SLAS2026 International Conference & Exhibition, taking place February 7–11 in Boston, Massachusetts. Agilent will demonstrate how its expanding automation ecosystem—integrating advanced imaging, software, robotics, and AI‑powered optimization—supports laboratories in accelerating discovery with confidence, efficiency, and superior data quality.
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25
Agilent Technologies Inc. (
NYSE: A) will release financial results for the first quarter of fiscal year 2026 after the stock market closes on Wednesday, Feb. 25. The company will host a conference call to discuss the results at 1:30 p.m. PST the same day.
Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System
Agilent Technologies Inc. (
NYSE: A) today announced the launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, available for sale in key European markets. The launch reflects Agilent’s continued investment in digital pathology, expanding its portfolio to meet the growing demand for high-throughput solutions in clinical laboratories.
Metavesco Congratulates DeFi Dev Corp on Becoming the Second Publicly Traded Company to Launch a MemecoinSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Metavesco Congratulates DeFi Dev Corp on Becoming the Second Publicly Traded Company to Launch a MemecoinCUMMING, GA - January 22, 2026 (NEWMEDIAWIRE) - Metavesco, Inc. (OTC: MVCO), a diversified holding company and the architect of the growing OTCfi ecosystem, today congratulated DeFi Dev Corp on the launch of its DONT memecoin, marking DeFi Dev Corp as the second publicly traded company to launch a memecoin.
3 Healthcare Stocks Walking a Fine LineFrom novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising
as the industry has posted a 23.7% gain over the past six months, beating the S&P 500 by 13.6 percentage points.
Why Agilent (A) Stock Is Up TodayShares of life sciences tools company Agilent Technologies (
NYSE:A)
jumped 2.8% in the afternoon session after Evercore ISI upgraded the company's stock to 'Outperform' from 'In-Line' and raised its price target.
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We IgnoreWall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference
Agilent Technologies Inc. (
NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will present at the 44th Annual J.P. Morgan Healthcare Conference at 9 to 9:40 a.m. PST on Tuesday, Jan. 13, 2026.
